|
6 Companies |
|
8 Products |
|
8 Products |
|
13 Mechanisms of Action |
|
0 Trials |
|
37 News |
|
- | Avastin (bevacizumab) / Roche
Phase classification: Bevacizumab Injection for Recurrent Pterygium (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=38, Completed, Sponsor: Instituto de Oftalmolog
Phase classification: P1 --> P=N/A
- | Trial completion, Enrollment change, Trial initiation date, Trial primary completion date, Surgery: Fibrin Glue vs. Suture in Pterygium Surgery (clinicaltrials.gov) - Aug 8, 2017
P=N/A, N=90, Completed, Sponsor: Dr. Guy Ben-Simon, MD
Phase classification: P1 --> P=N/A Recruiting --> Completed | N=60 --> 90 | Initiation date: Jan 2010 --> Jan 2014 | Trial primary completion date: Dec 2016 --> May 2016
- Lucentis (ranibizumab) / Roche, Novartis
Trial completion, Trial primary completion date: Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia (clinicaltrials.gov) - May 19, 2016
P1, N=10, Completed, Sponsor: University of New Mexico
Recruiting --> Completed | N=60 --> 90 | Initiation date: Jan 2010 --> Jan 2014 | Trial primary completion date: Dec 2016 --> May 2016 Recruiting --> Completed | Trial primary completion date: Jul 2012 --> Jul 2014
- Avastin (bevacizumab) / Roche
Trial completion, Surgery: Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery (clinicaltrials.gov) - Dec 9, 2015
P2, N=51, Completed, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Completed | Trial primary completion date: Jul 2012 --> Jul 2014 Active, not recruiting --> Completed
- Trial primary completion date, Surgery: Fibrin Glue vs. Suture in Pterygium Surgery (clinicaltrials.gov) - Dec 5, 2015
P=N/A, N=60, Recruiting, Sponsor: Dr. Guy Ben-Simon, MD
Active, not recruiting --> Completed Trial primary completion date: Dec 2012 --> Dec 2016
- Trial completion, Trial primary completion date: Determinants of Pterygium Occurrence and Recurrence in a Rural African Population (clinicaltrials.gov) - Jun 25, 2015
P=N/A, N=355, Completed, Sponsor: Anguria, Peter, M.D.
Trial primary completion date: Dec 2012 --> Dec 2016 Recruiting --> Completed | Trial primary completion date: Sep 2009 --> Feb 2012
- Avastin (bevacizumab) / Roche
Trial primary completion date, Surgery: Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery (clinicaltrials.gov) - Jun 11, 2015
P2, N=50, Active, not recruiting, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Completed | Trial primary completion date: Sep 2009 --> Feb 2012 Trial primary completion date: Feb 2015 --> Aug 2015
- Biomarker, Trial primary completion date: Risk Factors and Biomarkers Associated With Recurrence After Excision of Primary Pterygium (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=1, Terminated, Sponsor: Singapore National Eye Centre
Trial primary completion date: Feb 2015 --> Aug 2015 Trial primary completion date: Sep 2013 --> Dec 2014
- mitomycin / Generic mfg.
Trial completion, Surgery: Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane (clinicaltrials.gov) - Mar 20, 2015
P=N/A, N=96, Completed, Sponsor: Shiyou Zhou
Trial primary completion date: Sep 2013 --> Dec 2014 Recruiting --> Completed
- Lucentis (ranibizumab) / Roche, Novartis
New P2/3 trial: Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study (clinicaltrials.gov) - Jan 20, 2015
P2/3, N=36, Completed, Sponsor: University of Science Malaysia
- | Avastin (bevacizumab) / Roche
Enrollment closed, Trial primary completion date, Surgery: Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery (clinicaltrials.gov) - Dec 19, 2014
P2, N=50, Active, not recruiting, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Feb 2015
- mitomycin / Generic mfg.
Trial primary completion date, Surgery: Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane (clinicaltrials.gov) - Jun 18, 2014
P=N/A, N=96, Recruiting, Sponsor: Sun Yat-sen University
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Feb 2015 Trial primary completion date: Jun 2013 --> Jun 2014
- sevoflurane / Generic mfg.
Surgery: Different Hemostasis According to the Anesthetic Agents (clinicaltrials.gov) - May 26, 2014
P=N/A, N=66, Completed, Sponsor: Seoul National University Bundang Hospital
- sevoflurane / Generic mfg.
Trial completion, Surgery: Different Hemostasis According to the Anesthetic Agents (clinicaltrials.gov) - May 26, 2014
P=N/A, N=66, Completed, Sponsor: Seoul National University Bundang Hospital
Trial primary completion date: Jun 2013 --> Jun 2014 Not yet recruiting --> Completed
- Surgery: Comparison Between Sutureless and Glue Free Versus Sutured Limbal Conjunctival Autograft in Primary Pterygium Surgery (clinicaltrials.gov) - Dec 9, 2013
P=N/A, N=150, Completed, Sponsor: Shaaban Elwan
- Avastin (bevacizumab) / Roche
New P1 trial: Bevacizumab Injection for Recurrent Pterygium (clinicaltrials.gov) - Dec 8, 2013
P1, N=38, Completed, Sponsor: Instituto de Oftalmolog
- Trial completion, Surgery: Different Surgical Techniques for Pterygium Surgery (clinicaltrials.gov) - Nov 29, 2013
P=N/A, N=38, Completed, Sponsor: Instituto de Olhos de Goiania
Not yet recruiting --> Completed Not yet recruiting --> Completed
- Biomarker, Trial termination: Risk Factors and Biomarkers Associated With Recurrence After Excision of Primary Pterygium (clinicaltrials.gov) - Aug 31, 2013
P=N/A, N=1, Terminated, Sponsor: Singapore National Eye Centre
Not yet recruiting --> Completed Recruiting --> Terminated; Other and future studies on lipiview in pterygium will cover this current trial sufficiently.
- Biomarker, Enrollment change: Risk Factors and Biomarkers Associated With Recurrence After Excision of Primary Pterygium (clinicaltrials.gov) - Aug 31, 2013
P=N/A, N=1, Terminated, Sponsor: Singapore National Eye Centre
Recruiting --> Terminated; Other and future studies on lipiview in pterygium will cover this current trial sufficiently. N=100 --> 1
- Avastin (bevacizumab) / Roche
Trial completion: Topical Bevacizumab for Preventing Recurrent Pterygium (clinicaltrials.gov) - Apr 5, 2013
P3, N=24, Completed, Sponsor: Chulalongkorn University
N=100 --> 1 Recruiting --> Completed
- mitomycin / Generic mfg.
Enrollment open, Surgery: Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane (clinicaltrials.gov) - Dec 18, 2012
P=N/A, N=96, Recruiting, Sponsor: Sun Yat-sen University
Recruiting --> Completed Active, not recruiting --> Recruiting
- Avastin (bevacizumab) / Roche
New P2/3 trial: Subconjunctival Bevacizumab and Recurrent Pterygium (clinicaltrials.gov) - Dec 5, 2012
P2/3, N=36, Completed, Sponsor: Instituto de Olhos de Goiania
- Avastin (bevacizumab) / Roche
New P4 trial: Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management (clinicaltrials.gov) - Nov 27, 2012
P4, N=31, Completed, Sponsor: Arrowhead Regional Medical Center
- Avastin (bevacizumab) / Roche
New P1 trial: Bevacizumab for Primary Pterygium Treatment (clinicaltrials.gov) - Sep 16, 2012
P1, N=49, Completed, Sponsor: Instituto de Oftalmolog
- Lucentis (ranibizumab) / Roche, Novartis
Trial completion: Ranibizumab for the Inhibition of Neovascularization in Pterygia (clinicaltrials.gov) - Jul 23, 2012
P1, N=10, Completed, Sponsor: Bascom Palmer Eye Institute
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- |||| cyclosporine ophthalmic emulsion / Generic mfg.
Trial completion: Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium (clinicaltrials.gov) - May 16, 2012
P2, N=115, Completed, Sponsor: Allergan
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Rizaben (tranilast) / Kissei, Nuon Therapeutics
Enrollment change: TPS: Evaluation of Tranilast to Treat Pterygium Before Excision (clinicaltrials.gov) - Mar 11, 2012
P3, N=32, Completed, Sponsor: Gildasio Castello de Almeida Junior
Active, not recruiting --> Completed N=50 --> 32
- Rizaben (tranilast) / Kissei, Nuon Therapeutics
Trial completion: TPS: Evaluation of Tranilast to Treat Pterygium Before Excision (clinicaltrials.gov) - Mar 11, 2012
P3, N=32, Completed, Sponsor: Gildasio Castello de Almeida Junior
N=50 --> 32 Recruiting --> Completed
- Lucentis (ranibizumab) / Roche, Novartis
Enrollment open: Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia (clinicaltrials.gov) - Nov 8, 2011
P1, N=10, Recruiting, Sponsor: University of New Mexico
Recruiting --> Completed Not yet recruiting --> Recruiting